Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women.

Sarkar M, Dodge JL, Greenblatt RM, Kuniholm MH, DeHovitz J, Plankey M, Kovacs A, French AL, Seaberg EC, Ofotokun I, Fischl M, Overton E, Kelly E, Bacchetti P, Peters MG; Women’s Interagency HIV Study.

Clin Infect Dis. 2017 Oct 30;65(10):1695-1702. doi: 10.1093/cid/cix643.

PMID:
29020239
2.

Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression.

Rubin LH, Maki PM, Springer G, Benning L, Anastos K, Gustafson D, Villacres MC, Jiang X, Adimora AA, Waldrop-Valverde D, Vance DE, Bolivar H, Alden C, Martin EM, Valcour VG; Women's Interagency HIV Study.

Neurology. 2017 Oct 10;89(15):1594-1603. doi: 10.1212/WNL.0000000000004491. Epub 2017 Sep 13.

PMID:
28904086
3.

The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.

Keating SM, Dodge JL, Norris PJ, Heitman J, Gange SJ, French AL, Glesby MJ, Edlin BR, Latham PS, Villacres MC, Greenblatt RM, Peters MG; Women’s Interagency HIV Study.

PLoS One. 2017 Sep 13;12(9):e0181004. doi: 10.1371/journal.pone.0181004. eCollection 2017.

4.

Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.

Reid MJA, Baxi SM, Sheira LA, Landay AL, Frongillo EA, Adedimeji A, Cohen MH, Wentz E, Gustafson DR, Merenstein D, Hunt PW, Tien PC, Weiser SD; Womenʼs Interagency HIV Study (WIHS).

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):e132-e141. doi: 10.1097/QAI.0000000000001376.

PMID:
28328551
5.

Changes in Urinary Biomarkers Over 10 Years Is Associated With Viral Suppression in a Prospective Cohort of Women Living With HIV.

Baxi SM, Scherzer R, Jotwani V, Estrella MM, Abraham AG, Parikh CR, Bennett MR, Cohen MH, Nowicki MJ, Gustafson DR, Sharma A, Young MA, Shlipak MG; Womenʼs Interagency HIV Study (WIHS).

J Acquir Immune Defic Syndr. 2017 Apr 15;74(5):e138-e145. doi: 10.1097/QAI.0000000000001200.

PMID:
27759575
6.

Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.

Valcour VG, Rubin LH, Obasi MU, Maki PM, Peters MG, Levin S, Crystal HA, Young MA, Mack WJ, Cohen MH, Pierce CB, Adimora AA, Tien PC; Womenʼs Interagency HIV Study Protocol Team.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):266-73. doi: 10.1097/QAI.0000000000000957.

7.

Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV.

Baxi SM, Scherzer R, Greenblatt RM, Minkoff H, Sharma A, Cohen M, Young MA, Abraham AG, Shlipak MG; Womenʼs Interagency HIV Study (WIHS).

AIDS. 2016 Feb 20;30(4):609-18. doi: 10.1097/QAD.0000000000000958.

8.

Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients.

Baxi SM, Greenblatt RM, Bacchetti P, Jin C, French AL, Keller MJ, Augenbraun MH, Gange SJ, Liu C, Mack WJ, Gandhi M; Women’s Interagency HIV Study (WIHS).

PLoS One. 2015 Jun 8;10(6):e0129100. doi: 10.1371/journal.pone.0129100. eCollection 2015.

9.

Worth the weight: using inverse probability weighted Cox models in AIDS research.

Buchanan AL, Hudgens MG, Cole SR, Lau B, Adimora AA; Women's Interagency HIV Study.

AIDS Res Hum Retroviruses. 2014 Dec;30(12):1170-7. doi: 10.1089/AID.2014.0037.

10.

HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients.

Landay A, Golub ET, Desai S, Zhang J, Winkelman V, Anastos K, Durkin H, Young M, Villacres MC, Greenblatt RM, Norris PJ, Busch MP; Womenʼs Interagency HIV Study.

AIDS. 2014 Mar 13;28(5):739-43. doi: 10.1097/QAD.0000000000000150.

11.

Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.

McFall AM, Dowdy DW, Zelaya CE, Murphy K, Wilson TE, Young MA, Gandhi M, Cohen MH, Golub ET, Althoff KN; Women's Interagency HIV Study.

J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):289-98. doi: 10.1097/QAI.0b013e3182a095e9.

12.

A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.

Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, Dehovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, Aouizerat B; Women's Interagency HIV Study.

J Infect Dis. 2012 Nov;206(9):1453-61. doi: 10.1093/infdis/jis508. Epub 2012 Aug 20.

13.

Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.

Sarkar M, Bacchetti P, French AL, Tien P, Glesby MJ, Nowicki M, Plankey M, Gange S, Sharp G, Minkoff H, Peters MG; Women's Interagency HIV Study (WIHS).

Hepatology. 2012 Nov;56(5):1699-705. doi: 10.1002/hep.25859. Epub 2012 Aug 27.

14.

Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection.

Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, Watts DH, Wright RL, D'Souza G, Colie C, Strickler HD; Women's Interagency HIV Study Collaborative Study Group.

Obstet Gynecol. 2011 Oct;118(4):831-9. doi: 10.1097/AOG.0b013e31821a0f4d.

15.

The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.

Keating SM, Golub ET, Nowicki M, Young M, Anastos K, Crystal H, Cohen MH, Zhang J, Greenblatt RM, Desai S, Wu S, Landay AL, Gange SJ, Norris PJ; Women's Interagency HIV Study.

AIDS. 2011 Sep 24;25(15):1823-32. doi: 10.1097/QAD.0b013e3283489d1f.

16.

Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART.

Terzian AS, Holman S, Nathwani N, Robison E, Weber K, Young M, Greenblatt RM, Gange SJ; Women's Interagency HIV Study.

J Womens Health (Larchmt). 2009 Dec;18(12):1965-74. doi: 10.1089/jwh.2008.1090.

17.

HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

Khurana S, Norris PJ, Busch MP, Haynes BF, Park S, Sasono P, Mlisana K, Salim AK, Hecht FM, Mulenga J, Chomba E, Hunter E, Allen S, Nemo G, Rodriguez-Chavez IR; Women's Interagency HIV Study Collaborative Study Group, Margolick JB; Multicenter AIDS Cohort Study (MACS), Golding H.

J Clin Microbiol. 2010 Jan;48(1):281-5. doi: 10.1128/JCM.01573-09. Epub 2009 Nov 11.

18.

Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.

Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM; Women's Interagency HIV Study.

J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):482-91. Erratum in: J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):e120.

19.

Protease inhibitor levels in hair strongly predict virologic response to treatment.

Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM; Women's Interagency HIV Study (WIHS).

AIDS. 2009 Feb 20;23(4):471-8. doi: 10.1097/QAD.0b013e328325a4a9.

20.

Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).

Navazesh M, Mulligan R, Karim R, Mack WJ, Ram S, Seirawan H, Greenspan J, Greenspan D, Phelan J, Alves M; Oral Substudy of the Women's Interagency HIV Study Collaborative Study Group*.

Oral Dis. 2009 Jan;15(1):52-60. doi: 10.1111/j.1601-0825.2008.01456.x. Epub 2008 Nov 11.

Supplemental Content

Loading ...
Support Center